MENU
SNTI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Senti Biosciences (SNTI) Ownership - Who owns Senti Biosciences?
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases... Show more
Profile
Industry
N/A
Address
2 Corporate Drive
Phone
+1 650 239-2030
Employees
48
Web
https://www.sentibio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
38.46M
P/E Ratio
4.27
Total Cash
21.58M
Projected Growth
N/A
Total Debt
31.31M
Revenue
N/A
Risk (Beta)
1.56
Dividend Yield
N/A
Total Cash/Share
0.82
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SNTI
Capitalization
38.5M
P/E Ratio
4.27
Risk (Beta)
1.56
Dividend Yield
N/A
Total Cash
21.6M
Total Cash/Share
0.82
Total Debt
31.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
24.7M
P/B Ratio
1.56
Cash Flow
N/A
Earnings
-8.52
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
3.26
Current Revenue Per Employee
2090.16
Dividends Per Share - Security
N/A
EBITDA
-58.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-75.03
Shares Held By Institutions
19.8M
Shares Outstanding - Current
26.2M
Total Liabilities
43.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-58.120
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2 Corporate Drive
Phone
+1 650 239-2030
Employees
48
Web
https://www.sentibio.com